Professor | Xu Yang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xu Yang
Contact Information	xuyang_pucri@bjmu.edu.cn
Language ability	Chinese, English
Province	Beijing

Upload Avatar (500 x 500)

Name

Xu Yang

Contact Information

xuyang_pucri@bjmu.edu.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	2018 PhD in Medicine: Peking University 2015 MSc in Science: Peking University 2013 BSc in Science/Economics: Peking University
Work Experience	2023.08-present - Peking University - Department of Pharmacy Administration and Clinical Pharmacy - Associate Researcher 2021.06-2023.07 - Peking University - Clinical Research Institute - Associate Researcher 2019.02-2021.02 - Karolinska Institute - Department of Clinical Epidemiology and Biostatistics - Postdoctoral Researcher 2018.09-2019.01 - Peking University - National Institute of Health and Medical Big Data - Assistant Researcher
Awards	2023-2024: Best Abstract at the 60th European Renal Association Congress

University/Lab Affiliation and Title

Peking University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

2018 PhD in Medicine: Peking University
2015 MSc in Science: Peking University
2013 BSc in Science/Economics: Peking University

Work Experience

2023.08-present - Peking University - Department of Pharmacy Administration and Clinical Pharmacy - Associate Researcher
2021.06-2023.07 - Peking University - Clinical Research Institute - Associate Researcher
2019.02-2021.02 - Karolinska Institute - Department of Clinical Epidemiology and Biostatistics - Postdoctoral Researcher
2018.09-2019.01 - Peking University - National Institute of Health and Medical Big Data - Assistant Researcher

Awards

2023-2024: Best Abstract at the 60th European Renal Association Congress

Areas of Focus	Real-world safety and efficacy evaluation of drugs and medical devices
Publications	Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care, Xu Y, Evans M, Mazhar F, et al., 2023 Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes, Xu Y, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ, 2023 National incidence and mortality of hospitalized sepsis in China, Weng L#, Xu Y#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B and for the China Critical Care Clinical Trials G, 2023 GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes, Xu Y#, Fu EL#, Clase CM, Mazhar F, Jardine MJ, Carrero JJ, 2022 Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes, Xu Y, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ, 2022 Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study, Xu Y#, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ, 2021 Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease, Xu Y, Evans M, Soro M, Barany P, Carrero JJ, 2021 Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study, Xu Y, Evans M, Barany P, James G, Sjölander A and Carrero JJ, 2021 Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care, Xu Y, Surapaneni A, Alkas J, Evans M, Shin J-I, Selvin E, Chang A, Grams ME, Carrero JJ, 2020 Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China, Xu Y, Wang T, Yang Z, Lin H, Shen P, Zhan S, 2020

Areas of Focus

Real-world safety and efficacy evaluation of drugs and medical devices

Publications

Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care, Xu Y*, Evans M, Mazhar F, et al., 2023
Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes, Xu Y*, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ, 2023
National incidence and mortality of hospitalized sepsis in China, Weng L#, Xu Y#, Yin P#, Wang Y, Chen Y, Liu W, Li S, Peng JM, Dong R, Hu XY, Jiang W, Wang CY, Gao P, Zhou MG, Du B and for the China Critical Care Clinical Trials G, 2023
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes, Xu Y#*, Fu EL#, Clase CM, Mazhar F, Jardine MJ, Carrero JJ, 2022
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes, Xu Y, Fu EL, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ, 2022
Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study, Xu Y#, Li L#, Evans M, Xu H, Lindholm B, Carrero JJ, 2021
Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease, Xu Y, Evans M, Soro M, Barany P, Carrero JJ, 2021
Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study, Xu Y, Evans M, Barany P, James G, Sjölander A and Carrero JJ, 2021
Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care, Xu Y*, Surapaneni A, Alkas J, Evans M, Shin J-I, Selvin E, Chang A, Grams ME, Carrero JJ, 2020
Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population-based cohort study in China, Xu Y, Wang T, Yang Z, Lin H, Shen P, Zhan S, 2020

Real-World Safety Efficacy Evaluation Drugs Medical Devices Pharmacovigilance Clinical Outcomes Healthcare Regulatory Science

Ning Ding - Fudan University

Danyan Zhu - Zhejiang University

Yong Jiang - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us